The Lancet, Sep 2024
The programme involves 12 weeks of low-calorie diet (shakes and soups) followed by the reintroduction of food, focusing on movement and maintaining a new healthy eating lifestyle.
After discussing the service with your patient and confirming eligibility please complete the referral form which is embedded into your clinical system and send it to: scwcsu.hiowt2dr@nhs.net
To be eligible for the programme, you must be:
Aged 18‑65;
Diagnosed with type 2 diabetes within the last 6 year;
Have a BMI of 27kg/m2 or higher in people from a white background (or 25kg/m² or higher in people from all other ethnic groups;
HbA1c measurement within the last 12 months of 43‑87 mmol/mol if taking diabetes medication or 48‑87 mmol/mol if not taking diabetes medication;
Patient has attended a diabetes review when this was last offered, inc. retinal screening, and commits to continue attending annual reviews, even if remission is achieved. (If a patient is newly diagnosed then there is no requirement to wait for retinal screening to take place before offering referral)
Current insulin user
Pregnant or planning to become pregnant within the next 12 months
Currently breastfeeding
Has at least one of the following significant co‑morbidities; Active cancer; Heart attack or stroke in last 6 months; Severe heart failure (defined as New York Heart Association grade 3 or 4) Severe renal impairment (most recent eGFR less than 30mls/min/1.73m2)
Active liver disease other than non‑alcoholic fatty liver disease (NAFLD) (i.e. NAFLD is not an exclusion criterion)
Active substance use disorder
Active eating disorder (including binge eating disorder)
Known proliferative retinopathy that has not been treated (this does not exclude individuals who are newly diagnosed and have not yet had the opportunity for retinal screening)
Has had bariatric surgery
Health professional assessment that the person is unable to understand or meet the demands of the programme and/ or monitoring requirements (due to physical or psychological conditions or co‑morbidities)
Discharged in the last 12 months from the NHS Type 2 Diabetes Path to Remission Programme after having commenced the programme (for clarity, this does not apply to people previously referred to the programme but who dropped out or declined prior to commencing the TDR Phase)
A clinical search will provide a list of possible eligible patients; however, the exclusion criteria of the programme and readiness/motivation must also be considered before making a referral
Supporting resources:
“The NHS Type 2 Diabetes Path to Remission Programme can help you reduce your diabetes medication and lose weight. Find out more by signing up to our information session: https://bit.ly/t2dr-info“
i.e. during routine consultations or annual reviews
Supporting resources:
De-prescribing guide
Please note, we no longer use Habitual total diet replacement products.
Xyla NHS Type 2 Diabetes Path to Remission Programme – Referrer case study
A brief overview of deprescribing from our Medical Director, Marlon
Contact your local Xyla Engagement Team
Email: HIOW-T2DR@xylaservices.com
View GP info sheetXyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)